Neoadjuvant chemotherapy (NAC) has become the standard treatment for locally advanced or invasive breast cancer, but with only 20 to 30% of patients achieving pathological complete response (pCR). Being able to predict non-responders to NAC would greatly improve patient care. In this context, the field of radiomics considers images as sources of a large amount of data and extracts shape, histogram-based and texture features to build decision-making tools. The goal of this thesis is to improve the prediction of pCR to NAC, with a particular focus on the normalization of images and the exportability of radiomic models.We used a retrospective multicentric database of 136 patients treated at Institut Curie and imaged using T1-weighted dynamic c...
Au-delà des techniques conventionnelles de diagnostic et de suivi du cancer, l’analyse radiomique a ...
La radiomique est une discipline basée sur le calcul de paramètres à partir d’images médicales et de...
Background For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete...
Neoadjuvant chemotherapy (NAC) has become the standard treatment for locally advanced or invasive br...
Breast cancer is one of the most common diseases in women around the world. This cancer is the leadi...
Radiomics is an emerging field based on the extraction of features computed from medical images. The...
Tumor shape and texture evolution may highlight internal modifications resulting from the progressio...
Purpose: We studied the performance of pre-therapeutic radiomic MRI analysis in order to predict the...
Beyond the conventional techniques of diagnosis and follow-up of cancer, radiomic analysis allows to...
Background Breast cancer response to neoadjuvant chemotherapy (NAC) is typically evaluated through t...
Breast cancer is the second most common type of cancer being the leading cause of cancer death among...
Le diagnostic assisté par ordinateur du cancer du sein suscite de plus en plus un réel engouement en...
Manual delineation of volumes of interest (VOIs) by experts is considered the gold-standard method i...
Women who are diagnosed with breast cancer are referred to Neoadjuvant Chemotherapy Treatment (NACT)...
Precision medicine (also known as personalized medicine) has been proposed to customize healthcare f...
Au-delà des techniques conventionnelles de diagnostic et de suivi du cancer, l’analyse radiomique a ...
La radiomique est une discipline basée sur le calcul de paramètres à partir d’images médicales et de...
Background For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete...
Neoadjuvant chemotherapy (NAC) has become the standard treatment for locally advanced or invasive br...
Breast cancer is one of the most common diseases in women around the world. This cancer is the leadi...
Radiomics is an emerging field based on the extraction of features computed from medical images. The...
Tumor shape and texture evolution may highlight internal modifications resulting from the progressio...
Purpose: We studied the performance of pre-therapeutic radiomic MRI analysis in order to predict the...
Beyond the conventional techniques of diagnosis and follow-up of cancer, radiomic analysis allows to...
Background Breast cancer response to neoadjuvant chemotherapy (NAC) is typically evaluated through t...
Breast cancer is the second most common type of cancer being the leading cause of cancer death among...
Le diagnostic assisté par ordinateur du cancer du sein suscite de plus en plus un réel engouement en...
Manual delineation of volumes of interest (VOIs) by experts is considered the gold-standard method i...
Women who are diagnosed with breast cancer are referred to Neoadjuvant Chemotherapy Treatment (NACT)...
Precision medicine (also known as personalized medicine) has been proposed to customize healthcare f...
Au-delà des techniques conventionnelles de diagnostic et de suivi du cancer, l’analyse radiomique a ...
La radiomique est une discipline basée sur le calcul de paramètres à partir d’images médicales et de...
Background For breast cancer patients undergoing neoadjuvant chemotherapy (NAC), pathologic complete...